Tekla Capital Management LLC Abb Vie Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 545,629 shares of ABBV stock, worth $92.2 Million. This represents 2.91% of its overall portfolio holdings.

Number of Shares

545,629

Previous 511,599 6.65%

Holding current value

$92.2 Million

Previous $81.5 Million 9.84%

% of portfolio

2.91%

Previous 3.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $4.51 Million - $5.61 Million	34,030 Added 6.65%	545,629 $73.5 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $4.81 Million - $5.54 Million	33,257 Added 6.95%	511,599 $81.5 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $6.71 Million - $8.04 Million	-48,500 Reduced 9.21%	478,342 $77.4 Million
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $5.37 Million - $6.16 Million	-40,000 Reduced 7.06%	526,842 $70.7 Million
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $2.57 Million - $3.27 Million	18,698 Added 3.41%	566,842 $86.8 Million

Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $5.06 Million - $6.28 Million	38,327 Added 7.52%	548,144 $88.9 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $1.55 Million - $1.96 Million	-14,396 Reduced 2.75%	509,817 $69 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $9.9 Million - $11.2 Million	-93,090 Reduced 15.08%	524,213 $56.5 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $258,395 - $287,867	-2,456 Reduced 0.4%	617,303 $69.5 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $20.5 Million - $27.7 Million	-254,961 Reduced 29.15%	619,759 $66.4 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $29.3 Million - $34.4 Million	340,995 Added 63.89%	874,720 $76.6 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $14.1 Million - $18.9 Million	192,809 Added 56.56%	533,725 $52.4 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $4.26 Million - $5.33 Million	-59,100 Reduced 14.77%	340,916 $30.2 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $4.2 Million - $5.05 Million	66,700 Added 20.01%	400,016 $30.3 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $860,867 - $1.1 Million	13,103 Added 4.09%	333,316 $24.2 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $13.3 Million - $15.6 Million	-171,865 Reduced 34.93%	320,213 $25.8 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $1.92 Million - $2.13 Million	-21,580 Reduced 4.2%	492,078 $46.5 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $5.65 Million - $6.68 Million	62,920 Added 13.96%	513,658 $47.6 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $9.61 Million - $12.9 Million	104,425 Added 30.15%	450,738 $42.7 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $21.7 Million - $23.7 Million	241,800 Added 231.36%	346,313 $33.5 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $7.29 Million - $9.31 Million	104,300 Added 48967.14%	104,513 $9.29 Million
Q2 2017 Aug 14, 2017	BUY	N/A	213	213 $15,000

Others Institutions Holding ABBV

# of Institutions

3,650

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $299B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Abb Vie Inc. Transaction History